Federal Register / Vol. 66, No. 109 / Wednesday, June 6, 2001 / Notices 30473

would constitute a clearly unwarranted

invasion of personal privacy.

Name of Committee: National Institute of

Mental Health Special Emphasis Panel.

Date: June 11, 2001.

Time: 2 p.m. to 3 p.m.

Agenda: To review and evaluate grant

applications.

Place: Neuroscience Center, National

Institutes of Health, 6001 Executive Blvd.,

Bethesda, MD 20892, (Telephone Conference

Call).

Contact Person: Martha Ann Carey, PhD.,

RN, Scientific Review Administrator,

Division of Extramural Activities, National

Institute of Mental Health, NIH,

Neuroscience Center, 6001 Executive Blvd.,

Room 6151, MSC 9608, Bethesda, MD 20892–

9608, 301–443–1606.

This notice is being published less than 15

days prior to the meeting due to the timing

limitations imposed by the review and

funding cycle.

(Catalogue of Federal Domestic Assistance

Program Nos. 93.242, Mental Health Research

Grants; 93.281, Scientist Development

Award, Scientist Development Award for

Clinicians, and Research Scientist Award;

93.282, Mental Health National Research

Service Awards for Research Training,

National Institutes of Health, HHS)

Dated: May 24, 2001.

LaVerne Y. Stringfield,

Director, Office of Federal Advisory

Committee Policy.

[FR Doc. 01–14160 Filed 6–5–01; 8:45 am]

BILLING CODE 4140–01–M

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

National Institutes of Health

National Institute on Drug Abuse;

Notice of Closed Meeting

Pursuant to section 10(d) of the

Federal Advisory Committee Act, as

amended (5 U.S.C. Appendix 2), notice

is hereby given of the following

meeting.

The meeting will be closed to the

public in accordance with the

provisions set forth in sections

552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,

as amended. The contract proposals and

the discussions could disclose

confidential trade secrets or commercial

property such as patentable material,

and personal information concerning

individuals associated with the contract

proposals, the disclosure of which

would constitute a clearly unwarranted

invasion of personal privacy.

Name of Committee: National Institute on

Drug Abuse Special Emphasis Panel,

‘‘Medicinal Chemistry-Synthesis of Potential

Treatment Agents for Cocaine Addiction’’.

Date: June 13, 2001.

Time: 9:00 AM to 5:00 PM.

Agenda: To review and evaluate contract

proposals.

Place: Double Tree Hotel, 1750 Rockville

Pike, Rockville, MD 20852.

Contact Person: Eric Zatman, Contract

Review Specialist, Office of Extramural

Affairs, National Institute on Drug Abuse,

National Institutes of Health, DHHS, 6001

Executive Boulevard, Room 3158, MSC 9547,

Bethesda, MD 20892–9547, (301) 435–1438.

This notice is being published less than 15

days prior to the meeting due to the timing

limitations imposed by the review and

funding cycle.

(Catalogue of Federal Domestic Assistance

Program Nos. 93.277, Drug Abuse Scientist

Development Award for Clinicians, Scientist

Development Awards, and Research Scientist

Awards; 93.278, Drug Abuse National

Research Service Awards for Research

Training; 93.279, Drug Abuse Research

Programs, National Institutes of Health, HHS)

Dated: May 30, 2001.

LaVerne Y. Stringfield,

Director, Office of Federal Advisory

Committee Policy.

[FR Doc. 01–14164 Filed 6–5–01; 8:45 am]

BILLING CODE 4140–01–M

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

National Institutes of Health

National Institute on Drug Abuse;

Notice of Closed Meetings

Pursuant to section 10(d) of the

Federal Advisory Committee Act, as

amended (5 U.S.C. Appendix 2), notice

is hereby given of the following

meetings.

The meetings will be closed to the

public in accordance with the

provisions set forth in sections

552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,

as amended. The grant applications and

the discussions could disclose

confidential trade secrets or commercial

property such as patentable material,

and personal information concerning

individuals associated with the grant

applications, the disclosure of which

would constitute a clearly unwarranted

invasion of personal privacy.

Name of Committee: National Institute on

Drug Abuse Special Emphasis Panel,

Research Program Project.

Date: July 12, 2001.

Time: 1:00 PM to 5:00 PM.

Agenda: To review and evaluate grant

applications.

Place: Ritz-Carlton Hotel, 1250 S. Hayes

Street, Arlington, VA 22202.

Contact Person: Khursheed Asghar, PhD,

Chief, Basic Sciences Review Branch, Office

of Extramural Affairs, National Institute on

Drug Abuse, National Institutes of Health,

6001 Executive Boulevard, Room 3158, MSC

9547, Bethesda, MD 20892–9547, (301) 443–

2620.

Name of Committee: National Institute on

Drug Abuse Special Emphasis Panel, Health

Disparities: Drug Use and its Adverse

Behavioral, Social, Medical, and Mental

Health Consequences.

Date: July 19–20, 2001.

Time: 9:00 AM to 6:00 PM.

Agenda: To review and evaluate grant

applications.

Place: Hyatt Regency Bethesda, 7400

Wisconsin Avenue, Bethesda, MD 20814.

Contact Person: Marina L. Volkov, PhD,

Health Scientist Administrator, Office of

Extramural Program Review, National

Institute on Drug Abuse, National Institutes

of Health, DHHS, 6001 Executive Boulevard,

Room 3158, MSC 9547, Bethesda, MD 20892–

9547, (301) 435–1433.

Name of Committee: National Institute on

Drug Abuse Special Emphasis Panel, The

Transition from Drug Use to Addiction:

Unearthing the Switch.

Date: July 24–25, 2001.

Time: 8:30 AM to 5:00 PM.

Agenda: To review and evaluate grant

applications.

Place: Key Bridge Marriott, 1401 Lee

Highway, Arlington, VA 22209.

Contact Person: Mark R. Green, PhD, Chief,

CEASRB, Office of Extramural Affairs,

National Institute on Drug Abuse, National

Institutes of Health, DHHS, Suite 3158, 6001

Executive Boulevard, Bethesda, MD 20892–

9547, (301) 435–1431.

(Catalogue of Federal Domestic Assistance

Program Nos. 93.277, Drug Abuse Scientist

Development Award for Clinicians, Scientist

Development Awards, and Research Scientist

Awards; 93.278, Drug Abuse National

Research Service Awards for Research

Training; 93.279, Drug Abuse Research

Programs, National Institutes of Health, HHS)

Dated: May 30, 2001.

LaVerne Y. Stringfield,

Director, Office of Federal Advisory

Committee Policy.

[FR Doc. 01–14165 Filed 6–5–01; 8:45 am]

BILLING CODE 4140–01–M

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

National Institutes of Health

National Institute of Environmental

Health Sciences; Notice of Closed

Meeting

Pursuant to section 10(d) of the

Federal Advisory Committee Act, as

amended (5 U.S.C. Appendix 2), notice

is hereby given of the following

meeting.

The meeting will be closed to the

public in accordance with the

provisions set forth in sections

552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,

as amended. The grant applications and

the discussions could disclose

confidential trade secrets or commercial

property such as patentable material,

and personal information concerning